High Vista Strategies LLC Alaunos Therapeutics, Inc. Transaction History

High Vista Strategies LLC

  • $249 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
$2.2 - $3.71 $41,580 - $70,119
-18,900 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$1.9 - $4.98 $9,880 - $25,896
5,200 Added 37.96%
18,900 $46,000
Q3 2019

Nov 14, 2019
BUY
$4.13 - $6.94 $56,581 - $95,078
13,700 New
13,700 $59,000

Others Institutions Holding TCRT

# of Institutions
5
Shares Held
92.6K
Call Options Held
0
Put Options Held
0
View Full List

About Alaunos Therapeutics, Inc.

TCRT Quotes by TradingView
  • Ticker TCRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,182,000
  • Market Cap $443M
  • Description
  • Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...
More about TCRT
Track This Portfolio

Track High Vista Strategies LLC Portfolio

Follow High Vista Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email